Courage Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,000
| Closed | -$291K | – | 30 |
|
|
2022
Q1 | $291K | Hold |
4,000
| – | – | 0.28% | 30 |
|
|
2021
Q4 | $473K | Hold |
4,000
| – | – | 0.31% | 30 |
|
|
2021
Q3 | $537K | Hold |
4,000
| – | – | 0.29% | 32 |
|
|
2021
Q2 | $648K | Sell |
4,000
-2,000
| -33% | -$324K | 0.39% | 29 |
|
|
2021
Q1 | $482K | Hold |
6,000
| – | – | 0.35% | 32 |
|
|
2020
Q4 | $326K | Buy |
+6,000
| New | +$326K | 0.32% | 28 |
|
|
2018
Q4 | – | Sell |
-7,000
| Closed | -$200K | – | 18 |
|
|
2018
Q3 | $200K | Sell |
7,000
-8,800
| -56% | -$251K | 0.11% | 20 |
|
|
2018
Q2 | $432K | Buy |
+15,800
| New | +$432K | 0.32% | 16 |
|
|
2018
Q1 | – | Sell |
-7,200
| Closed | -$138K | – | 27 |
|
|
2017
Q4 | $138K | Buy |
+7,200
| New | +$138K | 0.1% | 22 |
|